Business

Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities

Azenta, Inc. (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, Azenta UK Ltd, has acquired UK Biocentre Limited, a leading provider of sample management, sample storage and high-throughput sample processing services in the United Kingdom. The total consideration was GBP 20.5 million, net of cash and inclusive of up to GBP 1.8 million in contingent consideration upon the completion of certain milestones.

articleAzenta, Inc.March 4, 20266/company/azenta-inc/news/azenta-completes-strategic-acquisition-of-uk-biocentre-limited-to-expand-biorepository-capabilities
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities

About this update from Azenta, Inc.

[{"type":"text","content":"BURLINGTON, Mass., March 4, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, Azenta UK Ltd, has acquired UK Biocentre Limited, a leading provider of sample management, sample storage and high-throughput sample processing services in the United Kingdom. The total consideration was GBP 20.5 million, net of cash and inclusive of up to GBP 1.8 million in contingent consideration upon the completion of certain milestones.","length":517,"tagName":"p"},{"type":"image","alt":"Azenta logo (PRNewsfoto/Azenta)","displaySize":"","headline":null,"caption":"Azenta logo (PRNewsfoto/Azenta)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":343,"url":"https://media.zenfs.com/en/prnewswire.com/64aaad2f8339993081e94ff0b6de0eee"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/SZ99.Q8D0oWqpFiTnxCf8A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTYwNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/64aaad2f8339993081e94ff0b6de0eee","width":400,"height":343}},"href":"https://mma.prnewswire.com/media/1636185/Azenta_Logo_v3.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The acquisition strengthens Azenta's ability to deliver end-to-end lifecycle solutions in the UK, a leading life science research epicenter, while expanding its presence in Europe by establishing the UK Biocentre as a European-wide operational hub to support pharmaceutical, biotechnology, academic, and public health customers across the region. This major hub will support our already established biorepository in Griesheim, Germany with current and new customers benefiting from expanded sample storage automated capabilities, reliable and fully integrated sample management and processing services, and a broader European footprint to support the region. UK Biocentre will continue to operate under its existing name.","length":725,"tagName":"p"},{"type":"text","content":"Founded in 2014, UK Biocentre supports large‑scale biomedical, pharmaceutical, and clinical studies, enabling life‑changing research across academic, pharmaceutical, and biotechnology communities. Its high‑quality, automated solutions have made it a trusted partner supporting critical scientific discoveries and population‑scale programs. UK Biocentre generated approximate...

More updates from Azenta, Inc.

Azenta, Inc.UK Biocentresample managementAzenta UK LtdUK Biocentre Limitedprocessing serviceslife sciencepharmaceutical